2025 revenue consensus $5.25B.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONC:
- BeOne Medicines’ New Study on BG-75202: A Potential Game-Changer in Cancer Treatment?
- BeOne Medicines Advances in Oncology with Promising BG-T187 Study
- BeOne Medicines Advances in Multiple Myeloma Treatment with Sonrotoclax Study
- BeOne Medicines Advances CLL Treatment with Promising Phase 3 Study
- BeOne Medicines Advances CLL and SLL Treatment with Promising Phase 3 Study